Citius Oncology, Inc. (CTOR) Stock Price History
Historical prices from 2024 to 2026
Loading 10-year price history...
CTOR Historical Performance
Short-Term Returns
CTOR Stock Price Trajectory (2024–2026)
As of May 8, 2026, Citius Oncology, Inc. (CTOR) trades at $0.90, representing a +6.4% return over the past year. The stock has delivered a -92.1% total return over five years (-39.8% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $49.00 on August 6, 2024. From this peak, CTOR has corrected -98.2%, currently trading 32% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers HALO (-7.1% 1Y), NKTR (+818.2% 1Y), and ADMA (-64.1% 1Y), CTOR has underperformed the peer group average. Compare CTOR vs HALO →
CTOR Historical Price Data (2025–2026)
Showing 30 of 451 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 0.91 | 0.91 | 0.88 | 0.90 | 64K | -0.92% |
| 2026-05-06 | 0.97 | 0.98 | 0.91 | 0.91 | 84K | -4.97% |
| 2026-05-05 | 0.93 | 0.96 | 0.93 | 0.96 | 29K | +4.01% |
| 2026-05-04 | 0.92 | 0.93 | 0.88 | 0.92 | 154K | -2.64% |
| 2026-05-01 | 0.90 | 0.98 | 0.90 | 0.94 | 169K | +7.39% |
| 2026-04-30 | 0.85 | 0.90 | 0.85 | 0.88 | 34K | +2.31% |
| 2026-04-29 | 0.90 | 0.90 | 0.81 | 0.86 | 80K | -0.80% |
| 2026-04-28 | 0.85 | 0.87 | 0.85 | 0.87 | 41K | -0.76% |
| 2026-04-27 | 0.89 | 0.89 | 0.85 | 0.87 | 69K | -0.41% |
| 2026-04-24 | 0.96 | 0.96 | 0.83 | 0.88 | 122K | -10.30% |
| 2026-04-23 | 0.95 | 0.99 | 0.93 | 0.98 | 254K | +4.04% |
| 2026-04-22 | 0.90 | 0.94 | 0.90 | 0.94 | 109K | +4.43% |
| 2026-04-21 | 0.91 | 0.91 | 0.89 | 0.90 | 64K | -2.61% |
| 2026-04-20 | 0.91 | 0.93 | 0.88 | 0.92 | 164K | +5.25% |
| 2026-04-17 | 0.86 | 0.92 | 0.80 | 0.88 | 185K | +9.03% |
| 2026-04-16 | 0.83 | 0.84 | 0.78 | 0.81 | 149K | +3.20% |
| 2026-04-15 | 0.80 | 0.87 | 0.78 | 0.78 | 152K | +0.01% |
| 2026-04-14 | 0.74 | 0.79 | 0.69 | 0.78 | 212K | +14.75% |
| 2026-04-13 | 0.67 | 0.68 | 0.65 | 0.68 | 51K | +0.71% |
| 2026-04-10 | 0.68 | 0.68 | 0.65 | 0.68 | 45K | +7.59% |
| 2026-04-09 | 0.63 | 0.67 | 0.62 | 0.63 | 90K | -2.30% |
| 2026-04-08 | 0.68 | 0.71 | 0.64 | 0.64 | 269K | -3.27% |
| 2026-04-07 | 0.68 | 0.69 | 0.62 | 0.66 | 188K | -3.38% |
| 2026-04-06 | 0.75 | 0.75 | 0.68 | 0.69 | 88K | -2.26% |
| 2026-04-02 | 0.65 | 0.83 | 0.65 | 0.70 | 433K | +8.47% |
| 2026-04-01 | 0.64 | 0.65 | 0.59 | 0.65 | 135K | +4.55% |
| 2026-03-31 | 0.55 | 0.65 | 0.49 | 0.62 | 335K | +25.74% |
| 2026-03-30 | 0.51 | 0.53 | 0.49 | 0.49 | 129K | -3.67% |
| 2026-03-27 | 0.53 | 0.54 | 0.51 | 0.51 | 250K | -5.40% |
| 2026-03-26 | 0.58 | 0.58 | 0.52 | 0.54 | 190K | -6.40% |
See CTOR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CTOR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CTOR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCTOR — Frequently Asked Questions
Quick answers to the most common questions about buying CTOR stock.
How has CTOR stock performed recently?
CTOR returned +6.4% over the past year, beating its 5-year annualized CAGR of -39.8%. The stock trades below its 200-day moving average, confirming the uptrend.
What is CTOR's all-time high price?
Citius Oncology, Inc. reached $49.00 on 2024-08-06. The 52-week high is $6.19. Current 1-year return of +6.4% places the stock closer to historical peaks.
Where can I download CTOR historical price data?
This page provides CTOR daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2024-2026, downloadable in CSV format.